$4.86
-0.14 (-2.70%)
Santarus, Inc. (NASDAQ:SNTS)
CAPS Rating:
A pharmaceutical company focused on acquiring, developing and commercializing proprietary products that address the needs of patients treated by gastroenterologists or primary care physicians.
RSS Headlines
Fool UK